Prospective Phase I Trial of Concurrent Full Dose Gemcitabine/Nab-paclitaxel and Ablative Radiation Therapy for Borderline and Locally Advanced Pancreatic Cancer

被引：0
|
作者：
Kim, H. [1 ]
Olsen, J. R. [2 ]
Wang-Gillam, A. [3 ]
Green, O. L. [1 ]
Fields, R. C. [4 ]
Hammill, C. [4 ]
Strasberg, S. [4 ]
Doyle, M. B. [4 ]
Hawkins, W. [4 ]
Suresh, R. [5 ]
Tan, B. [5 ]
Pedersen, K. [5 ]
Henke, L. E. [1 ]
DeWees, T. A. [6 ]
Chapman, W. [4 ]
Parikh, P. J. [7 ]
Roach, M. C., Jr. [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA
[2] Washington Univ, Sch Med, St Louis, CO USA
[3] Washington Univ, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Med, Div Hematol Oncol, St Louis, MO 63110 USA
[6] Mayo Clin, Dept Biomed Informat, Scottsdale, AZ USA
[7] Henry Ford Hlth Syst, Dept Radiat Oncol, Detroit, MI USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1203
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [41] A phase 1 study of neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel, followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in locally advanced pancreatic cancer
    Park, Haeseong
    Poklepovic, Andrew
    CANCER RESEARCH, 2014, 74 (19)
  • [42] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
    Picozzi, Vincent
    Alseidi, Adnan
    Winter, Jordan
    Pishvaian, Michael
    Mody, Kabir
    Glaspy, John
    Larson, Timothy
    Matrana, Marc
    Carney, Mairead
    Porter, Seth
    Kouchakji, Elias
    Rocha, Flavio
    Carrier, Ewa
    ESMO OPEN, 2020, 5 (04)
  • [44] NAB-PACLITAXEL IN THE TREATMENT OF ADVANCED PANCREATIC CANCER REFRACTORY TO GEMCITABINE - FINAL RESULTS OF A PHASE 2 TRIAL
    Lopes, G. de Lima
    Hosein, P.
    Gomez, C.
    Pastorini, V.
    Macintyre, J.
    Easey, M.
    Reis, I.
    Merchan, J.
    Bejarano, P.
    Rocha-Lima, C.
    EJC SUPPLEMENTS, 2011, 9 (01): : 1 - 1
  • [45] A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement
    Ikenaga, Naoki
    Miyasaka, Yoshihiro
    Ohtsuka, Takao
    Nakata, Kohei
    Adachi, Tomohiko
    Eguchi, Susumu
    Nishihara, Kazuyoshi
    Inomata, Masafumi
    Kurahara, Hiroshi
    Hisaka, Toru
    Baba, Hideo
    Nagano, Hiroaki
    Ueki, Toshiharu
    Noshiro, Hirokazu
    Tokunaga, Shoji
    Ishigami, Kousei
    Nakamura, Masafumi
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 193 - 202
  • [46] Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer
    Nishida, Tsutomu
    Tsutsui, Shusaku
    Yamamoto, Katsumi
    Konishi, Koji
    Hayashi, Yoshito
    Iijima, Hideki
    Tsujii, Masahiko
    Takeda, Yutaka
    Kitagawa, Toru
    Yoshioka, Yasuo
    Inoue, Takehiro
    Hayashi, Norio
    PANCREATOLOGY, 2010, 10 (01) : 60 - 65
  • [47] A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
    Chun, Stephen G.
    Hughes, Randall
    Sumer, Baran D.
    Myers, Larry L.
    Truelson, John M.
    Khan, Saad A.
    Ma, Tsung-Wei
    Xie, Yang
    Yordy, John S.
    Cooley, Susan
    Wu, Jean
    Choy, Hak
    Nedzi, Lucien A.
    CANCER INVESTIGATION, 2017, 35 (01) : 23 - 31
  • [48] Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma
    Nebot-Villacampa, Maria-Jose
    Zafra-Morales, Ricardo
    Alfaro-Olea, Ascension
    Marin-Gorricho, Raquel
    Casajus-Navasal, Andrea
    Uriarte-Pinto, Moises
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 603 - 611
  • [49] Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Waypa, Jordan
    Coats, Jessica
    Blaydorn, Lisa
    McGahey, Kayla
    Sangal, Ashish
    Whitehead, Robert P.
    Khemka, Vivek
    CANCER RESEARCH, 2017, 77
  • [50] Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
    Williet, Nicolas
    Petrillo, Angelica
    Roth, Gael
    Ghidini, Michele
    Petrova, Mila
    Forestier, Julien
    Lopez, Anthony
    Thoor, Audrey
    Weislinger, Lucie
    De Vita, Ferdinando
    Taieb, Julien
    Phelip, Jean Marc
    CANCERS, 2021, 13 (11)
12345